125 related articles for article (PubMed ID: 35090126)
1. Motor speech effects in subthalamic deep brain stimulation for Parkinson's disease.
Kluin KJ; Mossner JM; Costello JT; Chou KL; Patil PG
J Neurosurg; 2022 Sep; 137(3):722-728. PubMed ID: 35090126
[TBL] [Abstract][Full Text] [Related]
2. Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation.
Yamamoto T; Yamanaka Y; Hirano S; Higuchi Y; Kuwabara S
Front Neurol; 2022; 13():1042033. PubMed ID: 36686507
[TBL] [Abstract][Full Text] [Related]
3. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation on Motor Subtypes in Parkinson's Disease.
Fan S; Liu D; Shi L; Meng F; Fang H; Liu H; Zhang H; Yang A; Zhang J
World Neurosurg; 2022 Aug; 164():e245-e255. PubMed ID: 35489598
[TBL] [Abstract][Full Text] [Related]
5. Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?
Fabbri M; Zibetti M; Ferrero G; Accornero A; Guimaraes I; Rizzone MG; Romagnolo A; Ferreira JJ; Lopiano L
Parkinsonism Relat Disord; 2019 Jul; 64():242-248. PubMed ID: 31060986
[TBL] [Abstract][Full Text] [Related]
6. MDS-UPDRS to assess non-motor symptoms after STN DBS for Parkinson's disease.
Jafari N; Pahwa R; Nazzaro JM; Arnold PM; Lyons KE
Int J Neurosci; 2016; 126(1):25-9. PubMed ID: 26134878
[TBL] [Abstract][Full Text] [Related]
7. Dysarthria and Speech Intelligibility Following Parkinson's Disease Globus Pallidus Internus Deep Brain Stimulation.
Chiu SY; Tsuboi T; Hegland KW; Herndon NE; Shukla AW; Patterson A; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
J Parkinsons Dis; 2020; 10(4):1493-1502. PubMed ID: 32955467
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Iron Distribution in Deep Gray Matter Nuclei Measured by Quantitative Susceptibility Mapping and Motor Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease.
Zhao W; Yang C; Tong R; Chen L; Chen M; Gillen KM; Li G; Ma C; Wang Y; Wu X; Li J
J Magn Reson Imaging; 2023 Aug; 58(2):581-590. PubMed ID: 36594513
[TBL] [Abstract][Full Text] [Related]
9. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
[TBL] [Abstract][Full Text] [Related]
10. SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.
Nunta-Aree S; Sitthinamsuwan B; Boonyapisit K; Pisarnpong A
J Med Assoc Thai; 2010 May; 93(5):529-40. PubMed ID: 20524438
[TBL] [Abstract][Full Text] [Related]
11. Dorsal subthalamic deep brain stimulation improves pain in Parkinson's disease.
Askari A; Lam JLW; Zhu BJ; Lu CW; Chou KL; Wyant KJ; Patil PG
Front Pain Res (Lausanne); 2023; 4():1240379. PubMed ID: 37663307
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease.
Löser J; Luthardt J; Rullmann M; Weise D; Sabri O; Meixensberger J; Hesse S; Winkler D
J Neurosurg; 2021 Feb; 135(5):1429-1435. PubMed ID: 33607613
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
Tanaka Y; Tsuboi T; Watanabe H; Nakatsubo D; Maesawa S; Kato S; Kajita Y; Sato M; Oodake R; Hattori M; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
J Parkinsons Dis; 2020; 10(1):131-140. PubMed ID: 31884493
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the L-Dopa Response as a Predictor of Motor Outcomes After Deep Brain Stimulation in Parkinson's Disease.
Lin Z; Zhang X; Wang L; Zhang Y; Zhou H; Sun Q; Sun B; Huang P; Li D
Front Hum Neurosci; 2021; 15():604433. PubMed ID: 33613209
[No Abstract] [Full Text] [Related]
17. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
[TBL] [Abstract][Full Text] [Related]
18. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
[TBL] [Abstract][Full Text] [Related]
19. No differential effects of subthalamic nucleus vs. globus pallidus deep brain stimulation in Parkinson's disease: Speech acoustic and perceptual findings.
van Brenk F; Stipancic KL; Rohl AH; Corcos DM; Tjaden K; Greenlee JDW
IBRO Neurosci Rep; 2024 Jun; 16():361-367. PubMed ID: 38425546
[TBL] [Abstract][Full Text] [Related]
20. Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease.
Pinto S; Nebel A; Rau J; Espesser R; Maillochon P; Niebuhr O; Krack P; Witjas T; Ghio A; Cuartero MC; Timmermann L; Schnitzler A; Hesekamp H; Meier N; Müllner J; Hälbig TD; Möller B; Paschen S; Paschen L; Volkmann J; Barbe MT; Fink GR; Becker J; Reker P; Kühn AA; Schneider GH; Fraix V; Seigneuret E; Kistner A; Rascol O; Brefel-Courbon C; Ory-Magne F; Hartmann CJ; Wojtecki L; Fradet A; Maltête D; Damier P; Le Dily S; Sixel-Döring F; Benecke P; Weiss D; Wächter T; Pinsker MO; Régis J; Thobois S; Polo G; Houeto JL; Hartmann A; Knudsen K; Vidailhet M; Schüpbach M; Deuschl G;
Mov Disord; 2023 Feb; 38(2):212-222. PubMed ID: 36461899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
